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This Month in the Journal
This month, the Journal presents invited editorials that
discuss the implications of each of three newly discov-
ered mutations. In the first editorial, Lynn Hudson high-
lights the findings by Hodes et al. (p. 14), who have
discovered unusual duplications of an X-chromosomal
region. The duplicated copies, which include the gene
encoding proteolipid protein and lead to Pelizaeus-Merz-
bacher disease, are located distant to the original copy
of the region. Next, Zsolt Urba´n and Charles Boyd out-
line the types of elastin-fiber pathologies and discuss how
Hinek and colleagues (p. 23) have identified transport
defects that disrupt elastic-fiber assembly. Third, James
Lupski describes research by Mersiyanova et al. (p. 37)
defining mutations in the neurofilament-light gene that
lead to Charcot-Marie-Tooth disease type 2. Current
models of the pathology of demyelinating neuropathies
are discussed.
The connection between a genotype and a phenotype
is not always clear-cut, as is the case with the fragile X
premutation and premature ovarian failure (POF). In
our final editorial, Stephanie Sherman discusses three
studies that have been aimed at elucidating this connec-
tion. Murray et al. (p. 253) and Vianna-Morgante and
Costa (p. 254) have reexamined their data on POF, in
response to a recent article by Hundscheid et al. (66:
413–418), which had suggested a parent-of-origin effect
for this disorder. Unfortunately, neither of these groups
has been able to demonstrate a similar correlation be-
tween paternally inherited fragile X premutations and
POF in their study populations. Sherman discusses the
complexities of this field in the context of these three
studies and suggests that further studies must be per-
formed before the relationship between fragile X pre-
mutations and POF is resolved.
Identification of the HMSNL Gene, by Kalaydjieva et
al. (p. 47)
Hereditary motor and sensory neuropathy–Lom
(HMSNL) is an autosomal recessive form of Charcot-
Marie-Tooth disease that occurs in Romani groups de-
scended from a common founder population. Kalayd-
jieva et al. have collected a large sample of affected
families from several European countries and have used
haplotype analysis to narrow down the causative locus
for this disorder. They have identified mutations in a
gene within this region—N-myc downstream-regulated
gene 1 (NDRG1). All of the affected individuals in the
sample possessed the same mutation, an R148X trun-
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cating mutation. Furthermore, 6 of 10 additional fam-
ilies with unspecified autosomal recessive peripheral neu-
ropathies were found to have the R148X mutation in
NDRG1. Data in other systems have suggested that
NDRG1 plays a role in growth arrest and cell differ-
entiation during development, and the authors postulate
that, in the peripheral nervous system, this gene might
be important for both Schwann-cell differentiation and
the signaling necessary for axonal survival. This fits with
current models of Charcot-Marie-Tooth disease, as out-
lined in the editorial by Jim Lupski (p. 8).
p63 Mutations Cause SHFM, by Ianakiev et al. (p. 59)
The apical ectodermal ridge (AER) is a critical signaling
center in the developing limbs of tetrapods. This ridge
is crucial for the development of the thumb-pinky axis,
proper differentiation of cells in the developing limb,
and linear growth of the limb. Studies in mice have dem-
onstrated that p63 is required for the development and
maintenance of the AER, with homozygous p63 muta-
tions leading to defects in limb, craniofacial, and epi-
thelial development. These findings led to the discovery
that mutations in p63 in humans give rise to EEC (ec-
trodactyly, ectodermal dysplasia, and facial cleft) syn-
drome (see the 1999 article by Celli et al. that is cited
by Ianakiev et al.), a disorder with phenotypic manifes-
tations similar to those seen in p63-deficient mice. Split-
hand/split-foot malformation (SHFM) shares many of
the distal-limb abnormalities that are seen with EEC,
including median clefts of the hands and feet, absent or
stunted phalanges/metacarpals/metatarsals, and fusion
of digits. Ianakiev et al. present two families affected by
SHFM and two families affected by EEC. Mutations in
p63 are found in all four families, indicating that SHFM
and EEC are allelic disorders. Ianakiev et al. compare
the distribution of mutations leading to these two dis-
orders and suggest that the location of the mutation in
the p63 protein determines whether it will lead to SHFM
or EEC.
Genetic Regulation of Type 1 Diabetes, by Fox et al.
(p. 67)
Teasing apart the relationship between genetic loci and
phenotypes in complex, polygenic diseases can be a com-
plicated business. Not only are different individuals
likely to have mutations at different genetic loci, but each
individual may need to have mutations or polymor-
phisms at more than one locus before the phenotype is
seen. To facilitate genetic studies of such a complex dis-
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order—insulin-dependent diabetes mellitus—Fox et al.
have used the mouse nonobese diabetes (NOD) model
to examine the genetic correlates of one highly penetrant
step in the development of diabetes: T cell–dependent
progression to a destructive insulitis. Through linkage
analysis of the F2 progeny of NOD mice and the NOD
derivative strain NOR (i.e., NOD resistant), the authors
have been able to study the effects that various Idd loci
have on this step in diabetes pathogenesis and have
identified an interaction between NOD alleles at the
Idd5 and Idd13 loci that appears to contribute to T
cell–dependent insulitis. The human chromosomal re-
gions orthologous to Idd5 and Idd13 also show evidence
of linkage to diabetes risk, suggesting conservation of
the proteins involved in diabetes pathogenesis. These
results show that genetic analysis of simple phenotypes
may prove fruitful when analysis of a complex pheno-
type does not provide conclusive results.
Prostate Cancer Locus on Chromosome 20, by Berry et
al. (p. 82); Prostate Cancer–Aggressiveness Loci, by
Witte et al. (p. 92); and Genomic Scan of Families with
Prostate Cancer, by Gibbs et al. (p. 100)
Three articles on prostate cancer illustrate how diffi-
cult it is to identify the genetic loci involved in a complex
disease. Two of these articles, that by Berry et al. and
that by Gibbs et al., identify prostate cancer–sus-
ceptibility loci through genome scans. Berry et al. ex-
plore the evidence for a locus on chromosome 20q13,
whereas Gibbs et al. find putative loci on chromosomes
1, 8, 10–12, 14, and 16, with different results, depending
on the model and stratification that are used. Rather
than susceptibility loci, Witte et al. search for prostate
cancer–aggressiveness loci, using the Gleason score as a
quantitative trait. Their data suggest the presence of ag-
gressiveness loci at chromosomes 5q, 7q, and 19q. Dif-
ferences in sample ascertainment, analysis, and sample
stratification exist between the studies, so it is not sur-
prising that overlapping regions were not identified
among these studies. This lack of replication of results
in the field of prostate cancer genetics in general is dis-
heartening. However, advances are being made in un-
derstanding how sample stratification according to age
at diagnosis, the presence of male-to-male transmission,
and the number of affected family members affect these
scans. As more information is gained from studies such
as these, it will be possible to reduce the locus hetero-
geneity in study samples, which will likely increase the
replication of results.
Data Mining in LD Mapping, by Toivonen et al. (p.
133)
Haplotype pattern mining, a new nonparametricmethod
developed by Toivonen and colleagues for linkage-dis-
equilibrium mapping, uses algorithms to sift through
input haplotypes to identify repeated patterns. It is based
on the idea that individuals affected with a genetic dis-
order are likely to have higher frequencies of associated
marker alleles near the disease gene than are control
individuals. The algorithms are used to identify marker-
allele haplotypes that occur more frequently on chro-
mosomes containing the disease allele than on control
chromosomes. Not only can this method search multiple
regions at a time, but test analyses of simulated and real
data have proved it to have several additional benefits
over other linkage-disequilibrium methods. These ben-
efits include its robustness to missing and erroneous
data, the ability to detect disease loci in the presence of
high proportions of phenocopies, and the fact that this
method does not use model assumptions. The identifi-
cation of a disease locus for type I diabetes within a
region of strong background linkage disequilibrium il-
lustrates the utility of haplotype-pattern mining in de-
ciphering the genetics of complex disease.
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